University of Florida-ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2024

  1. A plasma peptidomic signature reveals extracellular matrix remodeling and predicts prognosis in alcohol-associated hepatitis

    Hepatology Communications, Vol. 8, Núm. 8

  2. KDM6A regulates immune response genes in multiple myeloma

    Blood

2023

  1. Does the duration of ambulatory consultations affect the quality of healthcare? A systematic review

    BMJ open quality, Vol. 12, Núm. 4

  2. Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology

    Neoplasia (United States), Vol. 42

2022

  1. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells

    Cell Metabolism, Vol. 34, Núm. 6, pp. 857-873.e9

2021

  1. A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC

    Hepatology Communications, Vol. 5, Núm. 3, pp. 538-547

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 7, pp. 757-767

  4. STATegra: Multi-Omics Data Integration – A Conceptual Scheme With a Bioinformatics Pipeline

    Frontiers in Genetics, Vol. 12

2020

  1. "a priori" Dietary Patterns and Cognitive Function in the SUN Project

    Neuroepidemiology, Vol. 54, Núm. 1, pp. 45-57

  2. Engineering and In Vitro Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced Seroreactivity

    Molecular Therapy - Methods and Clinical Development, Vol. 19, pp. 347-361

2018

  1. Heterogeneity within the PF-EPN-B ependymoma subgroup

    Acta Neuropathologica, Vol. 136, Núm. 2, pp. 227-237

2017

  1. Reversal of diabetes in NOD Mice by clinical-grade proinsulin and IL-10'secreting lactococcus lactis in combination with low-dose Anti-CD3 depends on the induction of Foxp3-Positive T Cells

    Diabetes, Vol. 66, Núm. 2, pp. 448-459

  2. UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition

    Cell Reports, Vol. 21, Núm. 3, pp. 628-640

1999

  1. Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: Current status and future directions

    Clinical Chemistry, Vol. 45, Núm. 10, pp. 1708-1717